Andere Sprachen PolyPid Ltd.

Aktien

A2JNTB

IL0011326795

PYPD

Verzögert Nasdaq Andere Börsenplätze 17:19:25 16.04.2024			% 5 Tage	% 1. Jan.
4.25 ^USD	-5.56%		0.00%	+11.84%

14.02.	Transcript : PolyPid Ltd., Q4 2023 Earnings Call, Feb 14, 2024
14.02.	PolyPid Ltd. meldet Ergebnis für das vierte Quartal und das Gesamtjahr bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference	28.02.
PolyPid Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14.02.
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	14.02.
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial	12.02.
PolyPid Ltd. Announces Enrollment of the 100th Patient in the Ongoing Shield II Phase 3 Trial	12.02.
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024	31.01.
PolyPid Ltd. announced that it has received $35.01012 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc.	22.01.
PolyPid Enters Into $16.2 Million Private Placement Deal	05.01.
PolyPid Announces Private Placement for $16 Million in Gross Proceeds	04.01.
PolyPid Ltd. announced that it expects to receive $16.216011 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc. and other investors	04.01.
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08.11.
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results	08.11.
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors	07.11.
Polypid Announces the Addition of Dr. Nurit Tweezer-Zaks to Its Board of Directors	07.11.
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023	01.11.
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule	11.10.23
POLYPID : AMENDED AND RESTATED 2012 SHARE OPTION PLAN - Form 6-K	10.10.23
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023	09.10.23
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform	05.10.23
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform	04.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PolyPid Ltd.

Aktien

A2JNTB

IL0011326795

PYPD

Andere Sprachen

Filter